{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:19:23Z","timestamp":1791227963800,"version":"4.1.0"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T00:00:00Z","timestamp":1628726400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T00:00:00Z","timestamp":1628726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s00296-021-04966-5","type":"journal-article","created":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T06:02:36Z","timestamp":1628748156000},"page":"1717-1728","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Classification of ANCA-associated vasculitis: differences based on ANCA specificity and clinicopathologic phenotype"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5792-199X","authenticated-orcid":false,"given":"Maricruz","family":"Dom\u00ednguez-Quintana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4712-441X","authenticated-orcid":false,"given":"Marco A.","family":"Alba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4001-3995","authenticated-orcid":false,"given":"Andrea","family":"Hinojosa-Azaola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,12]]},"reference":[{"key":"4966_CR1","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41572-020-0204-y","volume":"6","author":"AR Kitching","year":"2020","unstructured":"Kitching AR, Anders HJ, Basu N, Brouwer E, Gordon J, Jayne DR et al (2020) ANCA associated vasculitis. Nat Rev Dis Prim 6:71","journal-title":"Nat Rev Dis Prim"},{"key":"4966_CR2","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s00281-014-0436-6","volume":"36","author":"EF McKinney","year":"2014","unstructured":"McKinney EF, Willcocks LC, Broecker V, Smith KGC (2014) The immunopathology of ANCA-associated vasculitis. Semin Immunopathol 36:461\u2013478","journal-title":"Semin Immunopathol"},{"key":"4966_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-013-0383-6","author":"I Khan","year":"2013","unstructured":"Khan I, Watts RA (2013) Classification of ANCA-associated vasculitis. Curr Rheumatol Rep. https:\/\/doi.org\/10.1007\/s11926-013-0383-6","journal-title":"Curr Rheumatol Rep"},{"key":"4966_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/BOR.0000000000000134","volume":"27","author":"A Mahr","year":"2015","unstructured":"Mahr A, De Menthon M (2015) Classification and classification criteria for vasculitis: achievements, limitations and prospects. Curr Opin Rheumatol 27:1\u20139","journal-title":"Curr Opin Rheumatol"},{"key":"4966_CR5","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/S0001-7310(07)70150-3","volume":"98","author":"FJ Barbado-Hern\u00e1ndez","year":"2007","unstructured":"Barbado-Hern\u00e1ndez FJ, D\u00edaz-D\u00edaz RM, R\u00edos-Blanco JJ, G\u00f3mez-Cerezo JF, L\u00f3pez-Rodr\u00edguez M, Casado-Jim\u00e9nez M et al (2007) Historical perspective on the classification of vasculitis. Actas Dermosifiliogr 98:627\u2013638","journal-title":"Actas Dermosifiliogr"},{"key":"4966_CR6","doi-asserted-by":"publisher","first-page":"i14","DOI":"10.1093\/ndt\/gfv022","volume":"30","author":"RA Watts","year":"2015","unstructured":"Watts RA, Mahr A, Mohammad AJ, Gatenby P, Basu N, Flores-Su\u00e1rez LF (2015) Classification, epidemiology and clinical subgrouping of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. Nephrol Dial Transplant 30:i14-22","journal-title":"Nephrol Dial Transplant"},{"key":"4966_CR7","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1053\/j.ajkd.2019.04.031","volume":"75","author":"D Geetha","year":"2020","unstructured":"Geetha D, Jefferson JA (2020) ANCA-associated vasculitis: core curriculum 2020. Am J Kidney Dis 75:124\u2013137","journal-title":"Am J Kidney Dis"},{"key":"4966_CR8","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1136\/annrheumdis-2012-201750","volume":"72","author":"A Mahr","year":"2013","unstructured":"Mahr A, Katsahian S, Varet H, Guillevin L, Hagen EC, H\u00f6glund P et al (2013) Revisiting the classification of clinical phenotypes of anti-neutrophil cytoplasmic antibody-associated vasculitis: a cluster analysis. Ann Rheum Dis 72:1003\u20131110","journal-title":"Ann Rheum Dis"},{"issue":"Suppl. 1","key":"4966_CR9","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/j.1365-2249.2011.04359.x","volume":"164","author":"IM Bajema","year":"2011","unstructured":"Bajema IM (2011) Pathological classification of anti-neutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis. Clin Exp Immunol 164(Suppl. 1):14\u201316","journal-title":"Clin Exp Immunol"},{"key":"4966_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.37715","volume":"65","author":"JC Jennette","year":"2013","unstructured":"Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F et al (2013) 2012 Revised International Chapel Hill consensus conference nomenclature of vasculitides. Arthritis Rheum 65:1\u201311","journal-title":"Arthritis Rheum"},{"key":"4966_CR11","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1002\/art.22003","volume":"55","author":"JA Singh","year":"2006","unstructured":"Singh JA, Solomon DH, Dougados M, Felson D, Hawker G, Katz P et al (2006) Development of classification and response criteria for rheumatic diseases. Arthritis Care Res 55:348\u2013352","journal-title":"Arthritis Care Res"},{"key":"4966_CR12","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1002\/acr.22583","volume":"67","author":"R Aggarwal","year":"2015","unstructured":"Aggarwal R, Ringold S, Khanna D, Neogi T, Johnson SR, Miller A et al (2015) Distinctions between diagnostic and classification criteria? Arthritis Care Res (Hoboken) 67:891\u2013897","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"4966_CR13","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1681\/ASN.2009121238","volume":"21","author":"RJ Falk","year":"2010","unstructured":"Falk RJ, Jennette JC (2010) ANCA disease: where is this field heading? J Am Soc Nephrol 21:745\u2013752","journal-title":"J Am Soc Nephrol"},{"key":"4966_CR14","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0025-7125(16)31330-X","volume":"61","author":"D Alarcon-Segovia","year":"1977","unstructured":"Alarcon-Segovia D (1977) The necrotizing vasculitides. A new pathogenetic classification. Med Clin North Am 61:241\u2013260","journal-title":"Med Clin North Am"},{"key":"4966_CR15","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1080\/00325481.1975.11714169","volume":"58","author":"RD deShazo","year":"1975","unstructured":"deShazo RD (1975) The spectrum of systemic vasculitis: a classification to aid diagnosis. Postgrad Med 58:78\u201382","journal-title":"Postgrad Med"},{"key":"4966_CR16","doi-asserted-by":"publisher","first-page":"660","DOI":"10.7326\/0003-4819-89-5-660","volume":"89","author":"AS Fauci","year":"1978","unstructured":"Fauci AS, Haynes B, Katz P (1978) The spectrum of vasculitis: clinical, pathologic, immunologic and therapeutic considerations. Ann Intern Med 89:660\u2013676","journal-title":"Ann Intern Med"},{"key":"4966_CR17","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/art.1780370205","volume":"37","author":"JT Lie","year":"1994","unstructured":"Lie JT (1994) Nomenclature and classification of vasculitis: plus ca change, plus c\u2019est la meme chose. Arthritis Rheum 37:181\u2013186","journal-title":"Arthritis Rheum"},{"key":"4966_CR18","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1093\/ajcp\/22.8.777","volume":"22","author":"PM Zeek","year":"1952","unstructured":"Zeek PM (1952) Periarteritis nodosa: a critical review. Am J Clin Pathol 22:777\u2013790","journal-title":"Am J Clin Pathol"},{"key":"4966_CR19","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1002\/art.1780330806","volume":"33","author":"AT Masi","year":"1990","unstructured":"Masi AT, Hunder GG, Lie JT, Michel BA, Bloch DA, Arend WP et al (1990) The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 33:1094\u20131100","journal-title":"Arthritis Rheum"},{"key":"4966_CR20","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1002\/art.1780330807","volume":"33","author":"RY Leavitt","year":"1990","unstructured":"Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP et al (1990) The American College of Rheumatology 1990 criteria for the classification of Wegener\u2019s Granulomatosis. Arthritis Rheum 33:1101\u20131107","journal-title":"Arthritis Rheum"},{"key":"4966_CR21","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/art.1780370206","volume":"37","author":"JC Jennette","year":"1994","unstructured":"Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL et al (1994) Nomenclature of systemic vasculitides. Arthritis Rheum 37:187\u2013192","journal-title":"Arthritis Rheum"},{"key":"4966_CR22","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1136\/ard.2006.054593","volume":"66","author":"R Watts","year":"2007","unstructured":"Watts R, Lane S, Hanslik T, Hauser T, Hellmich B, Koldingsnes W et al (2007) Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis 66:222\u2013227","journal-title":"Ann Rheum Dis"},{"key":"4966_CR23","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1093\/rheumatology\/keq229","volume":"50","author":"RA Watts","year":"2011","unstructured":"Watts RA, Suppiah R, Merkel PA, Luqmani R (2011) Systemic vasculitis-is it time to reclassify? Rheumatology (Oxford) 50:643\u2013645","journal-title":"Rheumatology (Oxford)"},{"key":"4966_CR24","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/nrrheum.2014.104","volume":"10","author":"CGM Kallenberg","year":"2014","unstructured":"Kallenberg CGM (2014) Key advances in the clinical approach to ANCA-associated vasculitis. Nat Rev Rheumatol 10:484\u2013493","journal-title":"Nat Rev Rheumatol"},{"issue":"suppl 2","key":"4966_CR25","first-page":"46","volume":"58","author":"J Robson","year":"2019","unstructured":"Robson J, Grayson P, Ponte C, Suppiah R, Craven A, Khaild S et al (2019) Classification criteria for the ANCA-Associated vasculitides. Rheumatology (Oxford) 58(suppl 2):46\u201347","journal-title":"Rheumatology (Oxford)"},{"key":"4966_CR26","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0000000000001741","author":"VR Pimentel-Quiroz","year":"2021","unstructured":"Pimentel-Quiroz VR, S\u00e1nchez-Torres A, Re\u00e1tegui-Sokolova C, Gamboa-C\u00e1rdenas RV, S\u00e1nchez-Schwarts C, Medina-Chinch\u00f3n M et al (2021) Performance of the 2017 American College of Rheumatology\/European League Against Rheumatism Provisional Classification Criteria for Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in a Peruvian Tertiary Care Center. J Clin Rheumatol. https:\/\/doi.org\/10.1097\/RHU.0000000000001741","journal-title":"J Clin Rheumatol"},{"issue":"2","key":"4966_CR27","first-page":"85","volume":"111","author":"J Yoo","year":"2018","unstructured":"Yoo J, Kim HJ, Ahn SS, Jung SM, Song JJ, Park YB et al (2018) The utility of the ACR\/EULAR 2017 provisional classification criteria for granulomatosis with polyangiitis in Korean patients with antineutrophil cytoplasmic antibody-associated vasculitis. Clin Exp Rheumatol 111(2):85\u201387","journal-title":"Clin Exp Rheumatol"},{"key":"4966_CR28","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1681\/ASN.2010050477","volume":"21","author":"AE Berden","year":"2010","unstructured":"Berden AE, Ferrario F, Hagen EC, Jayne DR, Jennette JC, Joh K et al (2010) Histopathologic classification of ANCA-associated glomerulonephritis. J Am Soc Nephrol 21:1628\u20131636","journal-title":"J Am Soc Nephrol"},{"key":"4966_CR29","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/art.40375","volume":"70","author":"CH Sunderk\u00f6tter","year":"2018","unstructured":"Sunderk\u00f6tter CH, Zegler B, Chen KR, RequenaL PW, Carlson JA et al (2018) Nomenclature of cutaneous vasculitis: dermatologic addendum to the 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheumatol 70:171\u2013184","journal-title":"Arthritis Rheumatol"},{"key":"4966_CR30","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s00296-019-04406-5","volume":"40","author":"L Corral-Gudino","year":"2020","unstructured":"Corral-Gudino L, Gonz\u00e1lez-V\u00e1zquez E, Calero-Paniagua I, P\u00e9rez-Garrido L, Cusacovich I, Rivas-Lamazares A et al (2020) The complexity of classifying ANCA-associated small-vessel vasculitis in actual clinical practice: data from a multicenter retrospective survey. Rheumatol Int 40:303\u2013311","journal-title":"Rheumatol Int"},{"key":"4966_CR31","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/nrrheum.2017.140","volume":"13","author":"X Bossuyt","year":"2017","unstructured":"Bossuyt X, Cohen Tervaert JW, Arimura Y, Blockmans D, Flores-Su\u00e1ez LF, Guillevin L et al (2017) Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis. Nat Rev Rheumatol 13:683\u2013692","journal-title":"Nat Rev Rheumatol"},{"key":"4966_CR32","doi-asserted-by":"publisher","first-page":"17","DOI":"10.31138\/mjr.29.1.17","volume":"29","author":"E Csernok","year":"2018","unstructured":"Csernok E (2018) New concepts in ANCA detection and disease classification in small vessel vasculitis: the role of ANCA antigen specificity. Mediterr J Rheumatol 29:17\u201320","journal-title":"Mediterr J Rheumatol"},{"key":"4966_CR33","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1046\/j.1365-2796.1998.00357.x","volume":"244","author":"C Franssen","year":"1998","unstructured":"Franssen C, Gans R, Kallenberg C, Hageluken C, Hoorntje S (1998) Disease spectrum of patients with antineutrophil cytoplasmic autoantibodies of defined specificity: distinct differences between patients with anti-proteinase 3 and anti-myeloperoxidase autoantibodies. J Intern Med 244:209\u2013216","journal-title":"J Intern Med"},{"key":"4966_CR34","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/s11926-019-0872-3","volume":"21","author":"MS Osman","year":"2019","unstructured":"Osman MS, Tervaert JWC (2019) Anti-neutrophil cytoplasmic antibodies (ANCA) as disease activity biomarkers in a \u201cPersonalized Medicine Approach\u201d in ANCA-associated vasculitis. Curr Rheumatol Rep 21:76","journal-title":"Curr Rheumatol Rep"},{"key":"4966_CR35","doi-asserted-by":"publisher","first-page":"3452","DOI":"10.1002\/art.34562","volume":"64","author":"S Lionaki","year":"2012","unstructured":"Lionaki S, Blyth ER, Hogan SL, Hu Y, Senior BA, Jennette CE et al (2012) Classification of antineutrophil cytoplasmic autoantibody vasculitides: the role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis. Arthritis Rheum 64:3452\u20133462","journal-title":"Arthritis Rheum"},{"key":"4966_CR36","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.1002\/art.39812","volume":"68","author":"EM Miloslavsky","year":"2016","unstructured":"Miloslavsky EM, Lu N, Unizony S, Choi HK, Merkel PA, Seo P et al (2016) Myeloperoxidase-antineutrophil cytoplasmic antibody (ANCA)\u2013positive and ANCA-negative patients with granulomatosis with polyangiitis (Wegener\u2019s): distinct patient subsets. Arthritis Rheumatol 68:2945\u20132952","journal-title":"Arthritis Rheumatol"},{"key":"4966_CR37","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1093\/rheumatology\/kex293","volume":"56","author":"FA Pearce","year":"2017","unstructured":"Pearce FA, Craven A, Merkel PA, Luqmani RA, Watts RA (2017) Global ethnic and geographic differences in the clinical presentations of anti-neutrophil cytoplasm antibody-associated vasculitis. Rheumatology (Oxford) 56:1962\u20131969","journal-title":"Rheumatology (Oxford)"},{"key":"4966_CR38","first-page":"1","volume":"16","author":"K Sadaei","year":"2014","unstructured":"Sadaei K, Yamamura M, Harigai M, Fujii T, Dobashi H, Takasaki Y et al (2014) Classification and characteristics of Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis in a nationwide, prospective, inception cohort study. Arthritis Res Ther 16:1\u201310","journal-title":"Arthritis Res Ther"},{"key":"4966_CR39","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1093\/rheumatology\/kez148","volume":"58","author":"A Mahr","year":"2019","unstructured":"Mahr A, Specks U, Jayne D (2019) Subclassifying ANCA-associated vasculitis: a unifying view of disease spectrum. Rheumatology (Oxford) 58:1707\u20131709","journal-title":"Rheumatology (Oxford)"},{"issue":"Suppl 129","key":"4966_CR40","doi-asserted-by":"publisher","first-page":"62","DOI":"10.55563\/clinexprheumatol\/d01o72","volume":"39","author":"K W\u00f3jcik","year":"2021","unstructured":"W\u00f3jcik K, Biedro\u0144 G, Wawrzycka-Adamczyk K, Bazan-Socha S, \u0106miel A, Zdrojewski Z et al (2021) Subphenotypes of ANCA associated vasculitis identified by latent class analysis. Clin Exp Rheumatol 39(Suppl 129):62\u201368","journal-title":"Clin Exp Rheumatol"},{"key":"4966_CR41","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000006083","author":"R Solans-Laqu\u00e9","year":"2017","unstructured":"Solans-Laqu\u00e9 R, Fraile G, Rodriguez-Carballeira M, Caminal L, Castillo M, Mart\u00ednez-Valle F et al (2017) Impact of the vasculitis type, ANCA specificity, and treatment on mortality and morbidity. Medicine (Baltimore). https:\/\/doi.org\/10.1097\/MD.0000000000006083","journal-title":"Medicine (Baltimore)"},{"key":"4966_CR42","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1080\/14397595.2016.1192760","volume":"27","author":"T Murosaki","year":"2017","unstructured":"Murosaki T, Sato T, Akiyama Y, Nagatani K, Minota S (2017) Difference in relapse-rate and clinical phenotype by autoantibody-subtype in Japanese patients with anti-neutrophil cytoplasmic antibody-associated vasculitis. Mod Rheumatol 27:95\u2013101","journal-title":"Mod Rheumatol"},{"key":"4966_CR43","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1007\/s00296-019-04447-w","volume":"39","author":"SM Kim","year":"2019","unstructured":"Kim SM, Choi SY, Kim SY, Kim J (2019) Clinical characteristics of patients with vasculitis positive for anti-neutrophil cytoplasmic antibody targeting both proteinase 3 and myeloperoxidase: a retrospective study. Rheumatol Int 39:1919\u20131926","journal-title":"Rheumatol Int"},{"key":"4966_CR44","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.3899\/jrheum.161224","volume":"44","author":"AJ Mohammad","year":"2017","unstructured":"Mohammad AJ, Mortensen KH, Babar J, Smith R, Jones RB, Nakagomi D et al (2017) Pulmonary involvement in antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis: the influence of ANCA subtype. J Rheumatol 44:1458\u20131467","journal-title":"J Rheumatol"},{"key":"4966_CR45","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1093\/ndt\/gfu084","volume":"29","author":"LF Quintana","year":"2014","unstructured":"Quintana LF, Per\u00e9z NS, De Sousa E, Rodas LM, Griffiths MH, Sol\u00e9 M et al (2014) ANCA serotype and histopathological classification for the prediction of renal outcome in ANCA-associated glomerulonephritis. Nephrol Dial Transplant 29:1764\u20131769","journal-title":"Nephrol Dial Transplant"},{"key":"4966_CR46","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.3899\/jrheum.131038","volume":"41","author":"AJ Mohammad","year":"2014","unstructured":"Mohammad AJ, Segelmark M (2014) A population-based study showing better renal prognosis for proteinase 3 antineutrophil cytoplasmic antibody (ANCA)-associated nephritis versus myeloperoxidase ANCA-associated nephritis. J Rheumatol 41:1366\u20131373","journal-title":"J Rheumatol"},{"key":"4966_CR47","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1002\/art.20534","volume":"51","author":"D Albert","year":"2004","unstructured":"Albert D, Clarkin C, Komoroski J, Brensinger CM, Berlin JA (2004) Wegener\u2019s granulomatosis: possible role of environmental agents in its pathogenesis. Arthritis Rheum 51:656\u2013664","journal-title":"Arthritis Rheum"},{"key":"4966_CR48","doi-asserted-by":"publisher","first-page":"3392","DOI":"10.1038\/s41467-019-11255-0","volume":"10","author":"JD Ooi","year":"2019","unstructured":"Ooi JD, Jiang JH, Eggenhuizen PJ, Chua LL, van Timmeren M, Loh KL et al (2019) A plasmid-encoded peptide from Staphylococcus aureus induces anti-myeloperoxidase nephritogenic autoimmunity. Nat Commun 10:3392","journal-title":"Nat Commun"},{"key":"4966_CR49","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1056\/NEJMoa1108735","volume":"367","author":"PA Lyons","year":"2012","unstructured":"Lyons PA, Rayner TF, Trivedi S, Holle JU, Watts RA, Jayne DR et al (2012) Genetically distinct subsets within ANCA-associated vasculitis. N Engl J Med 367:214\u2013223","journal-title":"N Engl J Med"},{"key":"4966_CR50","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.autrev.2013.06.016","volume":"12","author":"JA Gomez-Puerta","year":"2013","unstructured":"Gomez-Puerta JA, Gedmintas L, Costenbader KH (2013) The association between silica exposure and development of ANCA-associated vasculitis: systematic review and meta-analysis. Autoimmun Rev 12:1129\u20131135","journal-title":"Autoimmun Rev"},{"key":"4966_CR51","first-page":"669","volume":"16","author":"GF Duna","year":"1998","unstructured":"Duna GF, Cotch MF, Galperin C, Hoffman DB, Hoffman GS (1998) Wegener\u2019s granulomatosis: role of environmental exposures. Clin Exp Rheumatol 16:669\u2013674","journal-title":"Clin Exp Rheumatol"},{"key":"4966_CR52","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1055\/s-0038-1673386","volume":"39","author":"MA Alba","year":"2018","unstructured":"Alba MA, Jennette JC, Falk RJ (2018) Pathogenesis of ANCA-associated pulmonary vasculitis. Semin Respir Crit Care Med 39:413\u2013424","journal-title":"Semin Respir Crit Care Med"},{"key":"4966_CR53","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nrrheum.2014.103","volume":"10","author":"JC Jennette","year":"2014","unstructured":"Jennette JC, Falk RJ (2014) Pathogenesis of antineutrophil cytoplasmic autoantibody-mediated disease. Nat Rev Rheumatol 10:463\u2013473","journal-title":"Nat Rev Rheumatol"},{"key":"4966_CR54","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.autrev.2015.06.008","volume":"14","author":"N Dumoitier","year":"2015","unstructured":"Dumoitier N, Terrier B, London J, Lofek S, Mouthon L (2015) Implication of B lymphocytes in the pathogenesis of ANCA-associated vasculitides. Autoimmun Rev 14:996\u20131004","journal-title":"Autoimmun Rev"},{"key":"4966_CR55","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1159\/000442323","volume":"1","author":"H Xiao","year":"2016","unstructured":"Xiao H, Hu P, Falk RJ, Jennette JC (2016) Overview of the pathogenesis of ANCA-associated vasculitis. Kidney Dis (Basel) 1:205\u2013215","journal-title":"Kidney Dis (Basel)"},{"key":"4966_CR56","first-page":"1077","volume":"7","author":"M Vargunam","year":"1992","unstructured":"Vargunam M, Adu D, Taylor CM, Michael J, Richards N, Neuberger J et al (1992) Endothelium myeloperoxidase-antimyeloperoxidase interaction in vasculitis. Nephrol Dial Transplant 7:1077\u20131081","journal-title":"Nephrol Dial Transplant"},{"key":"4966_CR57","doi-asserted-by":"publisher","first-page":"4115","DOI":"10.1073\/pnas.87.11.4115","volume":"87","author":"RJ Falk","year":"1990","unstructured":"Falk RJ, Terrell RS, Charles LA, Jennette JC (1990) Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci U S A 87:4115\u20134119","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Suppl 1","key":"4966_CR58","first-page":"i46","volume":"30","author":"U Schonermarck","year":"2015","unstructured":"Schonermarck U, Csernok E, Gross WL (2015) Pathogenesis of anti-neutrophil cytoplasmic antibody-associated vasculitis: challenges and solutions 2014. Nephrol Dial Transplant 30(Suppl 1):i46-52","journal-title":"Nephrol Dial Transplant"},{"key":"4966_CR59","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1681\/ASN.2019010032","volume":"31","author":"P Hu","year":"2020","unstructured":"Hu P, Su H, Xiao H, Gou SJ, Herrera CA, Alba MA et al (2020) Kinin B1 receptor is important in the pathogenesis of myeloperoxidase-specific ANCA GN. J Am Soc Nephrol 31:297\u2013307","journal-title":"J Am Soc Nephrol"},{"key":"4966_CR60","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1172\/JCI0215918","volume":"110","author":"H Xiao","year":"2002","unstructured":"Xiao H, Heeringa P, Hu P, Liu Z, Zhao M, Aratani Y et al (2002) Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest 110:955\u2013963","journal-title":"J Clin Invest"},{"key":"4966_CR61","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1002\/art.24790","volume":"61","author":"PA Gatenby","year":"2009","unstructured":"Gatenby PA, Lucas RM, Engelsen O, Ponsonby AL, Clements M (2009) Antineutrophil cytoplasmic antibody-associated vasculitides: could geographic patterns be explained by ambient ultraviolet radiation? Arthritis Rheum 61:1417\u20131424","journal-title":"Arthritis Rheum"},{"key":"4966_CR62","doi-asserted-by":"publisher","first-page":"473","DOI":"10.3899\/jrheum.160066","volume":"44","author":"MJ Kemna","year":"2017","unstructured":"Kemna MJ, Cohen Tervaert JW, Broen K, Timmermans S, van Paassen P, Damoiseaux J (2017) Seasonal influence on the risk of relapse at a rise of antineutrophil cytoplasmic antibodies in vasculitis patients with renal involvement. J Rheumatol 44:473\u2013481","journal-title":"J Rheumatol"},{"key":"4966_CR63","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1097\/00000478-199104000-00001","volume":"15","author":"WD Travis","year":"1991","unstructured":"Travis WD, Hoffman GS, Leavitt RY, Pass HI, Fauci AS (1991) Surgical pathology of the lung in Wegener\u2019s granulomatosis. Review of 87 open lung biopsies from 67 patients. Am J Surg Pathol 15:315\u2013333","journal-title":"Am J Surg Pathol"},{"key":"4966_CR64","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/ajcp\/104.1.7","volume":"104","author":"PB Gaudin","year":"1995","unstructured":"Gaudin PB, Askin FB, Falk RJ, Jennette JC (1995) The pathologic spectrum of pulmonary lesions in patients with anti-neutrophil cytoplasmic autoantibodies specific for anti-proteinase 3 and anti-myeloperoxidase. Am J Clin Pathol 104:7\u201316","journal-title":"Am J Clin Pathol"},{"issue":"1 Suppl 44","key":"4966_CR65","first-page":"S49","volume":"25","author":"P Lamprecht","year":"2007","unstructured":"Lamprecht P, Gross WL (2007) Current knowledge on cellular interactions in the WG-granuloma. Clin Exp Rheumatol 25(1 Suppl 44):S49-51","journal-title":"Clin Exp Rheumatol"},{"key":"4966_CR66","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1196\/annals.1361.042","volume":"1051","author":"J Voswinkel","year":"2005","unstructured":"Voswinkel J, Muller A, Lamprecht P (2005) Is PR3-ANCA formation initiated in Wegener\u2019s granulomatosis lesions? Granulomas as potential lymphoid tissue maintaining autoantibody production. Ann N Y Acad Sci 1051:12\u201319","journal-title":"Ann N Y Acad Sci"},{"key":"4966_CR67","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1002\/art.40034","volume":"69","author":"PA Merkel","year":"2017","unstructured":"Merkel PA, Xie G, Monach PA, Ji X, Ciavatta DJ, Byun J et al (2017) Identification of functional and expression polymorphisms associated with risk for antineutrophil cytoplasmic autoantibody-associated vasculitis. Arthritis Rheumatol 69:1054\u20131066","journal-title":"Arthritis Rheumatol"},{"key":"4966_CR68","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1097\/01.ASN.0000040751.83734.D1","volume":"14","author":"A Schreiber","year":"2003","unstructured":"Schreiber A, Busjahn A, Luft FC, Kettritz R (2003) Membrane expression of proteinase 3 is genetically determined. J Am Soc Nephrol 14:68\u201375","journal-title":"J Am Soc Nephrol"},{"key":"4966_CR69","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1097\/RHU.0000000000001030","volume":"25","author":"ME Mcclure","year":"2019","unstructured":"Mcclure ME, Wason J, Gopaluni S, Tieu J, Smith RM, Jayne DR et al (2019) Evaluation of PR3-ANCA status after Rituximab for ANCA-associated vasculitis. J Clin Rheumatol 25:217\u2013223","journal-title":"J Clin Rheumatol"},{"key":"4966_CR70","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1002\/art.39637","volume":"68","author":"LA Fussner","year":"2016","unstructured":"Fussner LA, Hummel AM, Schroeder DR, Silva F, Cartin-Ceba R, Snyder MR et al (2016) Factors determining the clinical utility of serial measurements of antineutrophil cytoplasmic antibodies targeting Proteinase 3. Arthritis Rheumatol 68:1700\u20131710","journal-title":"Arthritis Rheumatol"},{"key":"4966_CR71","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1002\/art.40538","volume":"70","author":"H Watanabe","year":"2018","unstructured":"Watanabe H, Sada KE, Matsumoto Y, Harigai M, Amano K, Dobashi H et al (2018) Association between reappearance of myeloperoxidase\u2013antineutrophil cytoplasmic antibody and relapse in antineutrophil cytoplasmic antibody\u2013associated vasculitis: subgroup analysis of nationwide prospective cohort studies. Arthritis Rheumatol 70:1626\u20131633","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"4966_CR72","doi-asserted-by":"publisher","first-page":"e247","DOI":"10.1016\/S2665-9913(19)30077-3","volume":"1","author":"JA Ford","year":"2019","unstructured":"Ford JA, Monach PA (2019) Disease heterogeneity in antineutrophil cytoplasmic antibody-associated vasculitis: implications for therapeutic approaches. Lancet Rheumatol 1(4):e247-256","journal-title":"Lancet Rheumatol"},{"key":"4966_CR73","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1136\/annrheumdis-2015-208073","volume":"75","author":"S Unizony","year":"2016","unstructured":"Unizony S, Villarreal M, Miloslavsky EM, Lu N, Merkel PA, Spiera R et al (2016) Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type. Ann Rheum Dis 75:1166\u20131169","journal-title":"Ann Rheum Dis"},{"key":"4966_CR74","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1136\/annrheumdis-2018-214245","volume":"78","author":"RB Jones","year":"2019","unstructured":"Jones RB, Hiemstra TF, Ballarin J, Blockmans DE, Brogan P, Bruchfeld A et al (2019) Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trial. Ann Rheum Dis 78:399\u2013405","journal-title":"Ann Rheum Dis"},{"key":"4966_CR75","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1002\/art.21142","volume":"52","author":"K De Groot","year":"2005","unstructured":"De Groot K, Rasmussen N, Bacon PA, Tervaert JWC, Feighery C, Gregorini G et al (2005) Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 52:2461\u20132469","journal-title":"Arthritis Rheum"},{"key":"4966_CR76","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1093\/rheumatology\/kez016","volume":"58","author":"S Deshayes","year":"2019","unstructured":"Deshayes S, Martin Silva N, Khoy K, Yameogo S, Mariotte D, Lobbedez T et al (2019) Clinical impact of subgrouping ANCA-associated vasculitis according to antibody specificity beyond the clinicopathological classification. Rheumatology (Oxford) 58:1731\u20131739","journal-title":"Rheumatology (Oxford)"},{"key":"4966_CR77","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1007\/s10067-016-3195-z","volume":"35","author":"BM C\u00f3rdova-S\u00e1nchez","year":"2016","unstructured":"C\u00f3rdova-S\u00e1nchez BM, Mej\u00eda-Vilet JM, Morales-Buenrostro LE, Loyola-Rodr\u00edguez G, Uribe-Uribe NO, Correa-Rotter R (2016) Clinical presentation and outcome prediction of clinical, serological, and histopathological classification schemes in ANCA-associated vasculitis with renal involvement. Clin Rheumatol 35:1805\u20131816","journal-title":"Clin Rheumatol"},{"key":"4966_CR78","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.2215\/CJN.01020113","volume":"8","author":"AAE de Joode","year":"2013","unstructured":"de Joode AAE, Sanders JSF, Stegeman CA (2013) Renal survival in proteinase 3 and Myeloperoxidase ANCA-associated systemic vasculitis. Clin J Am Soc Nephrol 8:1709\u20131717","journal-title":"Clin J Am Soc Nephrol"},{"key":"4966_CR79","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/nrrheum.2014.89","volume":"10","author":"GS Hoffman","year":"2014","unstructured":"Hoffman GS, Calabrese LH (2014) Vasculitis: determinants of disease patterns. Nat Rev Rheumatol 10:454\u2013462","journal-title":"Nat Rev Rheumatol"},{"issue":"Suppl. 1","key":"4966_CR80","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1365-2249.2011.04358.x","volume":"164","author":"RA Luqmani","year":"2011","unstructured":"Luqmani RA, Suppiah R, Grayson PC, Merkel PA, Watts R (2011) Nomenclature and classification of vasculitis-update on the ACR\/EULAR diagnosis and classification of vasculitis study (DCVAS). Clin Exp Immunol 164(Suppl. 1):11\u201313","journal-title":"Clin Exp Immunol"},{"key":"4966_CR81","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1681\/ASN.V82314","volume":"8","author":"RJ Falk","year":"1997","unstructured":"Falk RJ, Jennette JC (1997) ANCA small-vessel vasculitis. J Am Soc Nephrol 8:314\u2013322","journal-title":"J Am Soc Nephrol"},{"key":"4966_CR82","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2020.102467","author":"Y Nguyen","year":"2020","unstructured":"Nguyen Y, Pagnoux C, Karras A, Quemeneur T, Maurier F, Hamidou M et al (2020) Microscopic polyangiitis: clinical characteristics and long-term outcomes of 378 patients from the French Vasculitis Study Group Registry. J Autoimmun. https:\/\/doi.org\/10.1016\/j.jaut.2020.102467","journal-title":"J Autoimmun"},{"key":"4966_CR83","doi-asserted-by":"publisher","first-page":"488","DOI":"10.7326\/0003-4819-116-6-488","volume":"116","author":"GS Hoffman","year":"1992","unstructured":"Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD et al (1992) Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 116:488\u2013498","journal-title":"Ann Intern Med"},{"key":"4966_CR84","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.rdc.2010.05.008","volume":"36","author":"JU Holle","year":"2010","unstructured":"Holle JU, Laudien M, Gross WL (2010) Clinical manifestations and treatment of Wegener\u2019s granulomatosis. Rheum Dis Clin North Am 36:507\u2013526","journal-title":"Rheum Dis Clin North Am"},{"key":"4966_CR85","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1055\/s-0038-1669454","volume":"39","author":"Y Nguyen","year":"2018","unstructured":"Nguyen Y, Guillevin L (2018) Eosinophilic granulomatosis with polyangiitis (Churg-Strauss). Semin Respir Crit Care Med 39:471\u2013481","journal-title":"Semin Respir Crit Care Med"},{"key":"4966_CR86","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1002\/art.37721","volume":"65","author":"C Comarmond","year":"2013","unstructured":"Comarmond C, Pagnoux C, Khellaf M, Cordier JF, Hamidou M, Viallard JF et al (2013) Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort. Arthritis Rheum 65:270\u2013281","journal-title":"Arthritis Rheum"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-021-04966-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-021-04966-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-021-04966-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,5]],"date-time":"2023-02-05T18:04:33Z","timestamp":1675620273000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-021-04966-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,12]]},"references-count":86,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["4966"],"URL":"https:\/\/doi.org\/10.1007\/s00296-021-04966-5","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,12]]},"assertion":[{"value":"5 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"MDQ, MAA, and AHA declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}